stockrowFortrea Holdings Inc.
FTRE Healthcare Biotechnology
Fortrea Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 1.00% from fiscal 2024.
- Revenue
- −1.40%
- EPS
- +103.7%
- Free cash flow
- −34.0%
- Total debt
- −6.33%
Quarter to September 2026, against a year earlier
Follow FTRE
Alert me
Fortrea Holdings Inc. (FTRE) Operating margin
Fortrea Holdings Inc.'s operating margin over the twelve months to 30 September 2026 was 0.48%, up 32.5 percentage points from fiscal 2025 (−32.0%). Over the past ten years it has ranged from −32.0% (fiscal 2025) to 7.98% (fiscal 2020) — the current reading is the lowest in ten years. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −32.0% | (26.04) |
| FY2024 | −6.00% | (7.13) |
| FY2023 | 1.13% | (5.46) |
| FY2022 | 6.59% | 2.85 |
| FY2021 | 3.74% | (4.24) |
| FY2020 | 7.98% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 2.17% | (0.01) |
| Jun 2026 | 2.18% | 2.71 |
| Mar 2026 | −0.53% | 1.53 |
| Dec 2025 | −2.06% | (0.83) |
| 13 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| HRMY Harmony Biosciences Holdings, Inc. compare | 22.2% |
| FTRE Fortrea Holdings Inc. | 0.48% |
| IMNM Immunome, Inc. compare | 0.00% |
| REPL Replimune Group, Inc. compare | 0.00% |
| TRAX First Tracks Biotherapeutics, Inc. compare | 0.00% |
| BHVN Biohaven Ltd. compare | 0.00% |
| SRPT Sarepta Therapeutics, Inc. compare | −2.50% |
| VIR Vir Biotechnology, Inc. compare | −69.8% |
| ZYME Zymeworks Inc. compare | −419.0% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue